Elizabeth Grieshaber, MD
Dermatology · Metairie, LANPI 1437390424
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $117,158 of the $156,497 with a category attached, or 74.9%. Galderma Laboratories, L.p. accounts for 86.7% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2023 at $44,567 and has fallen 86.7% since, to $5,931 in 2025. Among dermatology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,286 payments — averaging $121.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$136K
- AbbVie$3K
- Johnson & Johnson$3K
- Lumenis, Inc$2K
- Novartis$1K
- Sun Pharmaceutical Industries Inc.$1K
- plus $10K from 36 others
What the payments were for
- Consulting fees$6,9004%
- Speaking & faculty fees$117,15875%
- Travel & lodging$4,8023%
- Food & beverage$26,94417%
- Education$6930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$156,497 in reported general payments places this provider in the 90th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $67,884 |
| Doxycycline Hyclate | 117 | $6,012 |
| Clobetasol Propionate | 80 | $3,318 |
| Fluocinonide | 48 | $1,638 |
| Ketoconazole | 91 | $1,566 |
| Tretinoin | 14 | $1,538 |
| Hydroxychloroquine Sulfate | 32 | $1,383 |
| Triamcinolone Acetonide | 150 | $1,283 |
| Fluorouracil | 18 | $1,024 |
| Azelaic Acid | 14 | $955 |
| ValacyclovirValacyclovir Hcl | 37 | $844 |
| Betamethasone Dipropionate | 19 | $739 |
| Minoxidil | 45 | $469 |
| Calcipotriene | 12 | $463 |
| Spironolactone | 23 | $430 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Metairie
- Katherine HolcombMetairie$411K
- Robert KoppelMetairie$212K
- Rachael Delahoussaye-ShieldsMetairie$83K
- Michelle GerdesMetairie$20K
- Diane RoseMetairie$9K
- Barbara BoppMetairie$9K
- William ClaiborneNew Orleans$374K
- Blair BuddenLafayette$329K
- Erin BohNew Orleans$277K
- Mara HaseltineNew Orleans$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.